On Monday, Immunovant Inc (NASDAQ: IMVT) was -3.63% drop from the session before settling in for the closing price of $25.91. A 52-week range for IMVT has been $12.72 – $27.69.
Healthcare Sector giant saw their annual sales slid by -12.18% over the last five years. When this article was written, the company’s average yearly earnings per share was at -6.01%. With a float of $83.65 million, this company’s outstanding shares have now reached $174.53 million.
Immunovant Inc (IMVT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Immunovant Inc stocks. The insider ownership of Immunovant Inc is 58.48%, while institutional ownership is 47.70%. The most recent insider transaction that took place on Dec 18 ’25, was worth 290,943. In this transaction Chief Legal Officer of this company sold 10,813 shares at a rate of $26.91, taking the stock ownership to the 149,930 shares. Before that another transaction happened on Dec 12 ’25, when Company’s Director bought 16,666,666 for $21.00, making the entire transaction worth $349,999,986. This insider now owns 113,317,007 shares in total.
Immunovant Inc (IMVT) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.76 earnings per share (EPS) during the time that was less than consensus figure (set at -0.75) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -6.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.34% during the next five years compared to -12.18% drop over the previous five years of trading.
Immunovant Inc (NASDAQ: IMVT) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.83, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -3.03 in one year’s time.
Technical Analysis of Immunovant Inc (IMVT)
Analysing the last 5-days average volume posted by the [Immunovant Inc, IMVT], we can find that recorded value of 1.48 million was lower than the volume posted last year of 1.83 million. As of the previous 9 days, the stock’s Stochastic %D was 20.78%.
During the past 100 days, Immunovant Inc’s (IMVT) raw stochastic average was set at 79.43%, which indicates a significant increase from 9.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.07 in the past 14 days, which was higher than the 1.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $23.99, while its 200-day Moving Average is $18.00. Now, the first resistance to watch is $25.68. This is followed by the second major resistance level at $26.39. The third major resistance level sits at $26.88. If the price goes on to break the first support level at $24.48, it is likely to go to the next support level at $23.99. Now, if the price goes above the second support level, the third support stands at $23.28.
Immunovant Inc (NASDAQ: IMVT) Key Stats
There are 175,277K outstanding shares of the company, which has a market capitalization of 5.03 billion. As of now, sales total 0 K while income totals -413,840 K. Its latest quarter income was 0 K while its last quarter net income were -126,500 K.
